TB-500
Evidence Level: preclinical
wound-healing, tendon-repair
Read more →
Photo from Pexels
The immune system is a distributed network of cells and signals that must balance vigilance with restraint — attacking threats while sparing healthy tissue. TB-500 and GHK-Cu approach immune support from fundamentally different angles [PMID: 22726581] [PMID: 22512572]. TB-500 influences immune cell migration and inflammatory resolution, while GHK-Cu supports the antioxidant defenses that protect immune cells during activation.
Effective immune defense requires coordinated migration of immune cells to sites of threat, appropriate cytokine release, and efficient resolution once the threat is cleared. Immune cell movement depends on actin dynamics, while the metabolic burst that kills pathogens generates oxidative stress that must be managed [PMID: 22726581].
When any part of this chain falters — cell trafficking, signaling, or antioxidant capacity — immune function can be compromised. This is why peptides that influence cell motility and oxidative defense attract research interest.
TB-500 (Thymosin Beta-4) plays a critical role in immune cell migration by binding to actin and regulating cytoskeletal dynamics. Preclinical studies demonstrate enhanced movement of endothelial cells and keratinocytes during tissue repair, processes that parallel immune cell trafficking [PMID: 22726581]. The peptide also exerts anti-inflammatory effects through NF-κB suppression, potentially helping resolve excessive immune activation.
Research in models of wound healing and tissue repair suggests TB-500 may help coordinate the transition from inflammatory to reparative immune phases. This immunomodulatory profile — supporting migration while reducing excessive inflammation — represents a distinctive mechanism among peptide candidates.
GHK-Cu supports immune function primarily through antioxidant activity and copper delivery to copper-dependent enzymes. Superoxide dismutase, an essential antioxidant enzyme, requires copper for proper function — and immune cells generate significant oxidative stress during pathogen killing [PMID: 22512572]. In cell culture models, GHK-Cu promotes processes that depend on coordinated immune activity.
The peptide also appears to modulate the expression of matrix metalloproteinases involved in immune cell migration through tissues. Copper's role in angiogenesis and tissue regeneration further positions GHK-Cu as a potential support for immune-competent tissue repair.
Immune-support applications of TB-500 and GHK-Cu remain almost entirely preclinical. No clinical trials have examined these peptides for immune support, infection resistance, or immune recovery in humans [PMID: 22726581]. While individual mechanisms are well-characterized, their translation to measurable improvements in human immune function is unknown.
| Compound | Tier | Evidence for This Use Case | Mechanisms of Action | Half-Life | Admin Routes |
|---|---|---|---|---|---|
| 1 TB-500 | Tier 1 | — | Actin sequestration and cytoskeletal remodeling, Angiogenesis promotion (VEGF pathway), Anti-inflammatory action (NF-κB suppression) | estimated days (based on Thymosin Beta-4 data) | subcutaneous, intramuscular |
| 2 GHK-Cu | Tier 1 | — | Collagen and elastin synthesis stimulation, Antioxidant gene expression upregulation, Angiogenesis and wound repair promotion | minutes to hours in plasma | subcutaneous, topical |
Evidence Level: preclinical
wound-healing, tendon-repair
Read more →Evidence Level: preclinical
skin-health, wound-healing
Read more →Limitless Life Nootropics — TB-500
Compound15Affiliate link — we may earn a commission at no extra cost to you. Research compounds are for laboratory use only.
Limitless Life Nootropics — GHK-Cu
Compound15Affiliate link — we may earn a commission at no extra cost to you. Research compounds are for laboratory use only.